InvestorsHub Logo
Followers 195
Posts 24737
Boards Moderated 0
Alias Born 04/03/2010

Re: HyGro post# 516545

Saturday, 09/24/2022 2:56:49 PM

Saturday, September 24, 2022 2:56:49 PM

Post# of 704656
The updated SAP, while still blinded, addressed this issue. Plus this is a rare and orphan disease. Recurrent patients to treat are even less AND there is no standard of care for rGBM. So this would be an improvement over no treatment AND if it is approved for newly diagnosed, then extending the indication to recurrent patients based on that data will, as I have explained previously given the 21st Century Cures Act, be very easy, especially with that data.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News